STOCK TITAN

GH Research PLC (GHRS) to speak at RBC Psychedelics Symposium panel

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

GH Research PLC, an Ireland-based biopharmaceutical company, reported that it will take part in a panel discussion at the RBC Capital Markets Psychedelics Symposium: A Trip Into The Future of Mental Health. The event is scheduled to be held virtually on January 22, 2026.

The company will be represented in this regulatory report by Julie Ryan, Vice President, Finance, who signed the submission on behalf of GH Research PLC. The filing is primarily informational and highlights the company’s participation in an industry-focused conference rather than providing financial or operating results.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of January 2026.
 
Commission File Number: 001-40530

GH Research PLC
(Exact name of registrant as specified in its charter)

Joshua Dawson House
Dawson Street
Dublin 2
D02 RY95
Ireland
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
 ☒  
Form 40-F
 



GH Research PLC will participate in a panel discussion during the RBC Capital Markets Psychedelics Symposium: A Trip Into The Future of Mental Health, which is scheduled to take place virtually on January 22, 2026.  


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
GH Research PLC
Date: January 22, 2026
 
   
 
By:
/s/ Julie Ryan
 
Name:
Julie Ryan
 
Title:
Vice President, Finance


2

FAQ

What event is GHRS (GH Research PLC) participating in?

GH Research PLC will participate in a panel discussion during the RBC Capital Markets Psychedelics Symposium: A Trip Into The Future of Mental Health.

When will GH Research PLC take part in the RBC Capital Markets Psychedelics Symposium?

The symposium, including the panel discussion featuring GH Research PLC, is scheduled to take place virtually on January 22, 2026.

Is the GH Research PLC appearance at the RBC Capital Markets Psychedelics Symposium in-person or virtual?

The company’s participation in the RBC Capital Markets Psychedelics Symposium is described as virtual.

Who signed the January 2026 GHRS Form 6-K report?

The report was signed on behalf of GH Research PLC by Julie Ryan, who is identified as the company’s Vice President, Finance.

Does this GHRS Form 6-K include financial results or major transactions?

No financial results or major transactions are described; the report focuses on GH Research PLC’s participation in an industry panel discussion.

Where is GH Research PLC headquartered?

GH Research PLC’s principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.

Gh Research Plc

NASDAQ:GHRS

GHRS Rankings

GHRS Latest News

GHRS Latest SEC Filings

GHRS Stock Data

1.03B
45.42M
31.47%
70.41%
3.54%
Biotechnology
Healthcare
Link
Ireland
Dublin